MedTrace Logo

Effect of Parecoxib on Post-craniotomy Pain

NCT00455117 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2013-05-30

No results posted yet for this study

Summary

Aim of this trial:

To investigate whether post-craniotomy analgesia with (i) intravenous (IV) parecoxib plus intravenous paracetamol is superior to (ii) intravenous paracetamol alone.

Study Hypothesis:

Post-operative analgesia with intravenous parecoxib in combination with intravenous paracetamol will be superior to intravenous paracetamol alone.

Conditions

  • Anaesthesia

Interventions

DRUG

Intravenous Parecoxib ('Dynastat' Pfizer)

parecoxib or placebo

Sponsors & Collaborators

  • Melbourne Health

    lead OTHER

Principal Investigators

  • Daryl L Williams, MBBS · Director of Anaesthesia, Royal Melbourne Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455117 on ClinicalTrials.gov